TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

TIOPRONIN

TIOPRONIN Cystine Disulfide Reduction
Approved 2021-04-26
5
Indications
--
Phase 3 Trials
4
Years on Market

Details

Status
Prescription
First Approved
2021-04-26
Routes
ORAL
Dosage Forms
TABLET, DELAYED RELEASE, TABLET

Companies

Active Ingredient: TIOPRONIN

TIOPRONIN Approval History

Loading approval history...

What TIOPRONIN Treats

2 indications

TIOPRONIN is approved for 2 conditions since its original approval in 2021. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Cystine Stone Formation
  • Cystinuria
Source: FDA Label
πŸ”¬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
πŸ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TIOPRONIN FDA Label Details

Pro

Indications & Usage

Tiopronin delayed-release tablets are indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone. Additional pediatric use information is approved for Mission Pharmacal Company’s Thiola EC (tiopronin) delayed release tablets. However, due to Mission Pharmacal Company’s marketing exclusivity rights, this drug product is not labeled with that information. Tiopronin delayed-release tablets ar...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.